Kuwait’s Ministry of Health made a notable revelation on Tuesday, confirming the presence of the new COVID-19 omicron variant, EG.5, which is part of a distinct subset of the virus. This variant has been identified across approximately 50 countries.
Authorities swiftly assured the public that the detection of the EG.5 variant aligns with anticipated developments and is not a cause for heightened concern. The ministry underscored the importance of maintaining adherence to prevention protocols, particularly among healthcare practitioners and leaders in therapeutic healthcare establishments.
Health experts have reported that the EG.5 variant does not induce more severe illness and is linked to symptoms akin to those associated with the XBB variants. These symptoms encompass a cough, sore throat, runny nose, fatigue, headache, muscle aches, and alterations in the sense of smell.
Stay vigilant and stay informed as countries worldwide navigate the evolving landscape of COVID-19 variants, with Kuwait’s disclosure serving as a reminder of the ongoing importance of preventive measures and health guidelines.
